Louise Wang Zhiying Humphrey

Array ( [id] => 9589112 [patent_doc_number] => 08778653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Method for reducing DNA impurities in viral compositions' [patent_app_type] => utility [patent_app_number] => 13/813897 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9643 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696684 [patent_doc_number] => 20110229906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS' [patent_app_type] => utility [patent_app_number] => 12/841171 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 44411 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229906.pdf [firstpage_image] =>[orig_patent_app_number] => 12841171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992569 [patent_doc_number] => 20110014222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Stereoisomer Peptides and Their Polymer Conjugates for HIV Disease' [patent_app_type] => utility [patent_app_number] => 12/836187 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17577 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014222.pdf [firstpage_image] =>[orig_patent_app_number] => 12836187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702644 [patent_doc_number] => 08088397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Human lymphocyte vaccine adjuvant' [patent_app_type] => utility [patent_app_number] => 12/824577 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 37 [patent_no_of_words] => 6859 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088397.pdf [firstpage_image] =>[orig_patent_app_number] => 12824577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054610 [patent_doc_number] => 20110110970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'CHIMERIC VACCINES' [patent_app_type] => utility [patent_app_number] => 12/824835 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29288 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110970.pdf [firstpage_image] =>[orig_patent_app_number] => 12824835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601557 [patent_doc_number] => 20100322943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC AFFINITY PURIFIED SPECIFIC POLYCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/816520 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14821 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322943.pdf [firstpage_image] =>[orig_patent_app_number] => 12816520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642089 [patent_doc_number] => 08367068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Use of triplex structure DNA in transferring nucleotide sequences' [patent_app_type] => utility [patent_app_number] => 12/813375 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 36 [patent_no_of_words] => 13705 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12813375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6382688 [patent_doc_number] => 20100316988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'METHOD AND DEVICE FOR FILTERING PLATELETS' [patent_app_type] => utility [patent_app_number] => 12/792259 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5679 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316988.pdf [firstpage_image] =>[orig_patent_app_number] => 12792259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8943765 [patent_doc_number] => 08496941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same' [patent_app_type] => utility [patent_app_number] => 12/792580 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 46 [patent_no_of_words] => 20167 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12792580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7576939 [patent_doc_number] => 20110290821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Anti-viral compositions and methods for administration' [patent_app_type] => utility [patent_app_number] => 12/802146 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 32927 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0290/20110290821.pdf [firstpage_image] =>[orig_patent_app_number] => 12802146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500601 [patent_doc_number] => 20100215681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/767069 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6463 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215681.pdf [firstpage_image] =>[orig_patent_app_number] => 12767069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6111106 [patent_doc_number] => 20110189651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Method and Device for Detecting Feline Immunodeficiency Virus' [patent_app_type] => utility [patent_app_number] => 12/761239 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9934 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189651.pdf [firstpage_image] =>[orig_patent_app_number] => 12761239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615812 [patent_doc_number] => 20100310572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Binding molecules capable of neutralizing rabies virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/798748 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 36168 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310572.pdf [firstpage_image] =>[orig_patent_app_number] => 12798748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202303 [patent_doc_number] => 20110065089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'NOVEL STRAIN OF SARS-ASSOCIATED CORONAVIRUS AND APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/754908 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 116 [patent_figures_cnt] => 116 [patent_no_of_words] => 44477 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12754908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228897 [patent_doc_number] => 20100183635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'GLYCOSYLATED SPECIFICITY EXCHANGERS' [patent_app_type] => utility [patent_app_number] => 12/748151 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18778 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183635.pdf [firstpage_image] =>[orig_patent_app_number] => 12748151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870372 [patent_doc_number] => 08465748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Vaccine compositions and methods containing an immunogen derived from equine arteritis virus' [patent_app_type] => utility [patent_app_number] => 12/730618 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10845 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12730618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234920 [patent_doc_number] => 20100266624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'HEPATITIS-C VIRUS TESTING' [patent_app_type] => utility [patent_app_number] => 12/728030 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 17863 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266624.pdf [firstpage_image] =>[orig_patent_app_number] => 12728030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550897 [patent_doc_number] => 20100233203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'OPTIMIZED EARLY-LATE PROMOTER COMBINED WITH REPEATED VACCINATION FAVORS CYTOTOXIC T CELL RESPONSE AGAINST RECOMBINANT ANTIGEN IN MVA VACCINES' [patent_app_type] => utility [patent_app_number] => 12/719987 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8856 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233203.pdf [firstpage_image] =>[orig_patent_app_number] => 12719987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994528 [patent_doc_number] => 08518410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Fusion protein with HIV antigen' [patent_app_type] => utility [patent_app_number] => 12/717804 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 50 [patent_no_of_words] => 33177 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12717804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9922325 [patent_doc_number] => 08980281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'High-yield transgenic mammalian expression system for generating virus-like particles' [patent_app_type] => utility [patent_app_number] => 12/704928 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 29 [patent_no_of_words] => 24633 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12704928 [rel_patent_id] =>[rel_patent_doc_number] =>)